Compare Edwards Lifesciences Corporation Common Stock (EW) vs Lamb Weston Holdings Inc (LW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Lamb Weston Holdings Inc — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while Lamb Weston Holdings Inc trades at $49.24 (market cap $6.63B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 7.5× Lamb Weston Holdings Inc's market cap, and Lamb Weston Holdings Inc pays a 3.16% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | LW | |
|---|---|---|
Market Cap | $49.44B | $6.63B |
Volume | 3,508,027 | 3,860,427 |
Sector | Health | Consumer Staples |
52-Week High | $95.18 | $66.57 |
52-Week Low | $72.65 | $38.48 |
Enterprise Value | $45.90B | $10.42B |
Typical Hold Time | — | 66 Days |
Dividend Yield | — | 3.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lamb Weston (LW) trades at $49.46, up 3.24% today, with a bullish technical signal and strong earnings beat history. The stock shows robust fundamentals with a P/E of 26.28 and ROE of 14.17%, supported by consistent revenue growth and positive cash flow trends. Recent news highlights cost savings exceeding $100M and upcoming Q1 earnings, while analyst consensus leans toward a hold with a $53.71 price target.
The outlook for LW is cautiously optimistic, with potential upside from margin recovery and earnings beats, but risks include profit margin volatility and legal scrutiny. Investors should weigh the stock's valuation against operational execution and market sentiment shifts ahead of earnings reports.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Lamb Weston Holdings Inc
Lamb Weston is the world's second-largest producer of branded and private-label frozen potato products, such as French fries, sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. The company also has a small appetizer business that produces onion rings, mozzarella sticks, and cheese curds. Including joint ventures, 63% of fiscal 2022 revenue was U.S.-based, with the remainder stemming from Europe, Canada, Japan, China, Korea, Mexico, and several other countries. Lamb Weston's customer mix is estimated 58% quick-serve restaurants, 19% full-service restaurants, 8% other food services (hotels, commercial cafeterias, arenas, schools), and 16% retail. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.
Read more on LW →
